The Middle East & Africa hyperpigmentation disorder treatment market was valued at US$ 530.30 million in 2022 and is expected to reach US$ 894.55 million by 2030; it is estimated to register a CAGR of 6.8% from 2022 to 2030.
In October 2022, Galderma launched ALASTIN Skincare A-LUMINATE BRIGHTENING SERUM based on PATH-3 Technology. The new product addition to the ALASTIN Skincare lineup is designed to help lower the appearance of surface hyperpigmentation without any irritating, harsh ingredients. Thus, novel products enabled by the PATH-3 technology are expected to emerge as new trends in the hyperpigmentation disorder treatment market during the forecast period.
By treatment type, the Middle East & Africa hyperpigmentation disorder treatment market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. The cosmeceutical segment held the largest share of the Middle East & Africa hyperpigmentation disorder treatment market share in 2023.
Novel Products Based on PATH-3 Technology Bolster Middle East & Africa Hyperpigmentation Disorder Treatment Market
ALASTIN has formulated the PATH-3 technology and validated it through gene expression and cellular models to counteract the pigmentary pathways. This technology helps prevent the recurrence of surface pigmentation and provides protection against future damage due to continued use. The PATH-3 technology also complements in-office treatments, including lasers, skin brightening treatments, and chemical peels. The lightweight, elegant, non-irritating serum used in PATH-3 is formulated without retinol or hydroquinone and is safe for long-term daily use. A novel topical product enabled by the PATH-3 technology has been proven effective and safe in treating facial dyschromia.In October 2022, Galderma launched ALASTIN Skincare A-LUMINATE BRIGHTENING SERUM based on PATH-3 Technology. The new product addition to the ALASTIN Skincare lineup is designed to help lower the appearance of surface hyperpigmentation without any irritating, harsh ingredients. Thus, novel products enabled by the PATH-3 technology are expected to emerge as new trends in the hyperpigmentation disorder treatment market during the forecast period.
Middle East & Africa Hyperpigmentation Disorder Treatment Market Overview
Israel, Iran, Iraq, Kuwait, Oman, Egypt, and Kenya are among the major contributors to the Rest of Middle East & Africa hyperpigmentation disorder treatment market. The diverse population in South Africa, with varying skin types and concerns, presents an opportunity for skincare providers to offer personalized solutions tailored to individual needs. This personalized approach, combined with increasing disposable income and a growing middle-class population, is driving the demand for effective hyperpigmentation treatments in the Rest of MEA. Overall, these factors are leading to the growth of the hyperpigmentation disorder treatment market in the region, with prospects for continued expansion in the future.Middle East & Africa Hyperpigmentation Disorder Treatment Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Hyperpigmentation Disorder Treatment Market Segmentation
The Middle East & Africa hyperpigmentation disorder treatment market is categorized into treatment type, condition, end user, and country.By treatment type, the Middle East & Africa hyperpigmentation disorder treatment market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. The cosmeceutical segment held the largest share of the Middle East & Africa hyperpigmentation disorder treatment market share in 2023.
- In terms of condition, the Middle East & Africa hyperpigmentation disorder treatment market is segmented into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. The melasma segment held the largest share of the Middle East & Africa hyperpigmentation disorder treatment market share in 2023.
- By end user, the Middle East & Africa hyperpigmentation disorder treatment market is hospitals, dermatology centers, and others. The hospital segment held the largest share of the Middle East & Africa hyperpigmentation disorder treatment market share in 2023.
- Based on country, the Middle East & Africa hyperpigmentation disorder treatment market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa segment held the largest share of Middle East & Africa hyperpigmentation disorder treatment market in 2023.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa hyperpigmentation disorder treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa hyperpigmentation disorder treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa hyperpigmentation disorder treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Middle East & Africa Hyperpigmentation Disorder Treatment Market - Key Market Dynamics
5. Hyperpigmentation Disorder Treatment Market - Middle East & Africa Analysis
6. Middle East & Africa Hyperpigmentation Disorder Treatment Market Analysis - by Treatment Type
7. Middle East & Africa Hyperpigmentation Disorder Treatment Market Analysis - by Condition
8. Middle East & Africa Hyperpigmentation Disorder Treatment Market Analysis - by End User
9. Middle East & Africa Hyperpigmentation Disorder Treatment Market - Country Analysis
10. Hyperpigmentation Disorder Treatment Market - Industry Landscape
11. Company Profiles
12. Appendix
List of Tables
List of Figures
Companies Mentioned
Some of the leading companies in the Middle East & Africa Hyperpigmentation Disorder Treatment Market include:- AbbVie Inc
- Bayer AG
- Galderma SA
- L'OREAL S.A.
- Lutronic Co Ltd
- Obagi Cosmeceuticals LLC
- Pierre Fabre SA
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 84 |
Published | March 2025 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 530.3 Million |
Forecasted Market Value ( USD | $ 894.55 Million |
Compound Annual Growth Rate | 6.8% |
Regions Covered | Africa, Middle East |
No. of Companies Mentioned | 7 |